Abstract:Background and Purpose: Breast cancer is one of the leading causes of death among women. RNA binding proteins (RBPs) play a vital role in the progression of many cancers. Functional investigation of RBPs may contribute to elucidating the mechanisms underlying tumor initiation, progression, and invasion, therefore providing novel insights into future diagnosis, treatment, and prognosis. Methods: We downloaded RNA sequencing data from the cancer genome atlas (TCGA) by UCSC Xena and identified relevant RBPs through an integrated bioinformatics analysis. We then analyzed biological processes of differentially expressed genes (DEGs) by DAVID, and established their interaction networks and performed pathway analysis through the STRING database to uncover potential biological effects of these RBPs. We also explored the relationship between these RBPs and the prognosis of breast cancer patients. Results: In the present study, we obtained 1092 breast tumor samples and 113 normal controls. After data analysis, we identified 90 upregulated and 115 downregulated RBPs in breast cancer. GO and KEGG pathway analysis indicated that these significantly changed genes were mainly involved in RNA processing, splicing, localization and RNA silencing, DNA transposition regulation and methylation, alkylation, mitochondrial gene expression, and transcription regulation. In addition, some RBPs were related to histone H3K27 methylation, estrogen response, inflammatory mediators, and translation regulation. Our study also identified five RBPs associated with breast cancer prognosis. Survival analysis found that overexpression of DCAF13, EZR, and MRPL13 showed worse survival, but overexpression of APOBEC3C and EIF4E3 showed better survival. Conclusion: In conclusion, we identified key RBPs of breast cancer through comprehensive bioinformatics analysis. These RBPs were involved in a variety of biological and molecular pathways in breast cancer. Furthermore, we identified five RBPs as a potential prognostic biomarker of breast cancer. Our study provided novel insights to understand breast cancer at a molecular level.

Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins

Novel Roles of RNA-binding Proteins in Drug Resistance of Breast Cancer: from Molecular Biology to Targeting Therapeutics

RNA binding proteins in cancer chemotherapeutic drug resistance

RNA-Binding Proteins in Breast Cancer: Biological Implications and Therapeutic Opportunities

Functional Role of RBP in Osteosarcoma: Regulatory Mechanism and Clinical Therapy.

Targeting the “tumor microenvironment”: RNA-binding proteins in the spotlight in colorectal cancer therapy

The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects

RNA-binding proteins and cancer metastasis.

RNA-binding Proteins in Ovarian Cancer: a Novel Avenue of Their Roles in Diagnosis and Treatment

RNA Binding Proteins as Potential Therapeutic Targets in Colorectal Cancer

Comprehensive Genomic Characterization of RNA-Binding Proteins Across Human Cancers.

Multidimensional Crosstalk Between RNA-binding Proteins and Noncoding RNAs in Cancer Biology.

New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer

Unveiling the veil of RNA binding protein phase separation in cancer biology and therapy

Integrated Bioinformatics Analysis the Function of RNA Binding Proteins (RBPs) and Their Prognostic Value in Breast Cancer

Research Progress on RNA‑binding Proteins in Breast Cancer (Review)

RBM38 in Cancer: Role and Mechanism

The role of lncRNA binding to RNA‐binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review)

Role of the RNA-binding protein family in gynecologic cancers.

A comprehensive in silico expression analysis of RNA binding proteins in normal and tumor tissue; identification of potential players in tumor formation

RNA-binding proteins in tumor progression